HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin.

Abstract
Deficiency of vitamin A has been shown to cause squamous metaplasia of the epithelium of the tracheobronchial tree. Vitamin A analogues, such as retinoid acid, have been shown to be effective in the treatment of various skin disorders in humans; these compounds have also caused a reduction in the incidence of carcinogen-induced tumors in experimental animals. For these reasons, a clinical trial with orally administered 13-CIS retinoic acid was conducted in 26 patients with varying degrees of cytologic abnormalities in sputum, ranging from moderately atypical metaplasia to overt carcinoma. The drug was administered in daily doses from 1 to 2.5 mg/kg or until toxicity was observed. The cytologic effects of the drug were monitored in sputum. The treatment did not affect the quantitative aspects of sputum cytology. However, degenerative alterations were observed in many of the abnormal cells. Although the experience with 13-CIS retinoic acid reported in this paper is too small for statistical analysis, the cytotoxic effects observed are sufficiently intriguing to suggest further studies in humans and experimental animals.
AuthorsG Saccomanno, P G Moran, R Schmidt, D F Hartshorn, D A Brian, W H Dreher, B J Sowada
JournalActa cytologica (Acta Cytol) 1982 Jan-Feb Vol. 26 Issue 1 Pg. 78-85 ISSN: 0001-5547 [Print] Switzerland
PMID7039202 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carcinoembryonic Antigen
  • Tretinoin
  • Isotretinoin
Topics
  • Adult
  • Aged
  • Carcinoembryonic Antigen (analysis)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Isomerism
  • Isotretinoin
  • Lung Neoplasms (drug therapy, pathology)
  • Middle Aged
  • Precancerous Conditions (drug therapy, pathology)
  • Sputum (cytology)
  • Tretinoin (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: